NeuroPace, Inc.
Status: Publicly traded
Direct answer
NeuroPace, Inc. is publicly traded on NASDAQ under the ticker NPCE.
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable...
Can you invest in NeuroPace, Inc.?
Yes. NeuroPace, Inc. trades publicly on NASDAQ as NPCE.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for NeuroPace, Inc.
Detailed equity research is provided by MarketSnap.